Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Mounjaro) and chronic weight management (under the brand name Zepbound)
GLP-1 agonists can improve both mental and physical health, potentially enhancing treatment engagement
Therefore, always discuss any changes with your healthcare provider before making a switch or adjusting the dose
Your first visit lasts about an hour
The first weeks on medication bring significant adjustment
When a patient ceases taking the medication, the weight can be regained
